A/s Novo, 10% Owner at Corvus Pharmaceuticals, Inc. (CRVS), bought 70,000 shares at $10.00 ($700K) on 2016-05-12, disclosed to the SEC on 2016-05-16.
Open-market purchase of $700k CRVS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |